Publication: Osteopetrosis: Gene-based nosology and significance dysosteosclerosis
Loading...
Files
Date
2022-11-16
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Dysosteosclerosis (DSS) refers to skeletal dysplasias that radiographically feature focal appendicular osteo-
sclerosis with variable platyspondyly. Genetic heterogeneity is increasingly reported for the DSS phenotype and
now involves mutations of SLC29A3, TNFRSF11A, TCIRG1, LRRK1, and CSF1R. Typical radiological findings are
widened radiolucent long bones with thin cortices yet dense irregular metaphyses, flattened vertebral bodies,
dense ribs, and multiple fractures. However, the radiographic features of DSS evolve, and the metaphyseal and/
or appendicular osteosclerosis variably fades with increasing patient age, likely due to some residual osteoclast
function. Fractures are the principal presentation of DSS, and may even occur in infancy with SLC29A3-asso-
ciated DSS. Cranial base sclerosis can lead to cranial nerve palsies such as optic atrophy, and may be the initial
presentation, though not observed with SLC29A3-associated DSS. Gene-specific extra-skeletal features can be the
main complication in some forms of DSS such as CSF1R- associated DSS. Further genetic heterogeneity is likely,
especially for X-linked recessive DSS and cases currently with an unknown genetic defect. Distinguishing DSS can
be challenging due to variable clinical and radiological features and an evolving phenotype. However, defining
the DSS phenotype is important for predicting complications, prognosis, and instituting appropriate health
surveillance and treatment.
1. Introduction
Dysosteosclerosis (DSS) is regarded as a skeletal dysplasia (OMIM %
224,300) [1] and was first described in 1934 by Ellis [2] who described
2 brothers from consanguineous English parents and, considered it
osteopetrosis (OPT). In 1968, Spranger and colleagues described the
disease as a distinct entity [3]. Spranger described the radiological
features in a 12-year-old boy as widened radiolucent long bones with
thin cortices ends to the dense irregular metaphyses, flattened vertebral
bodies, dense ribs, and multiple fractures [3]. DSS is categorized as an
osteosclerotic disease, rather than a nonhomogeneous osteosclerosis (i.
e. coexistence of radiolucent bones together with dense bones), to
differentiate DSS from OPT. Nevertheless, DSS is classified as an OPT-
related disorder by the International Skeletal Dysplasia Registry [4] in
line with the first report of Ellis [2]. Clinical features of DSS are recur-
rent fractures, short stature, failure of tooth eruption, and, sometimes
optic atrophy and other cranial nerve palsies, developmental delay, and
skin changes [2,3,5–11]. As radiological and clinical findings are vari-
able (See below) making a diagnosis can be challenging. Clinical and
radiological criteria for DSS are shown in Table 1.
Since DSS mimics the clinical and radiological findings of OPT to a
degree, candidate gene defects that compromise osteoclast function
and/or osteoclastogenesis may be causal. In 2010, Whyte et al. reported
an American girl of Turkish heritage with DSS, but with histological
features that suggested this was an “osteoclast-poor” form of OPT with a
skeletal resorption defect and absence of osteoclasts in bone biopsy [5].
In 2012, delineation of the genetic basis for DSS began with detecting
compound heterozygous loss-of-function mutations (c.607 T > C, p.
* Marmara University School of Medicine, Department of Paediatric Endocrinology and Diabetes, Fevzi Cakmak Mh. Muhsin Yazicioglu Cd. No 41. 34899, Ust-
kaynarca/Pendik, Istanbul, Turkey.
E-mail address: serap.turan@marmara.edu.tr.
Contents lists available at ScienceDirect
Bone
journal homepage: www.elsevier.com/locate/bone
https://doi.org/10.1016/j.bone.2022.116615
Received 3 July 2022; Received in revised form 9 November 2022; Accepted 12 November 2022
Description
Keywords
Ysosteosclerosis, Bone fractures, Osteopetrosis, Osteosclerosis, Osteopenia, Optic atrophy, Jaw necrosis, Metaphyseal osteosclerosis, Osteosclerotic metaphyseal dysplasia, Pyle disease, Brain abnormalities, Neurodegeneration, Dementia, Leukoencephalopathy, SLC29A3, TNFRSF11A, TCIRG1, LRRK1, CSF1R, TNFSF11
Citation
Turan S., "Osteopetrosis: Gene-based nosology and significance dysosteosclerosis.", Bone, ss.116615, 2022